SCOTT J. RATNER, M.D.
To the editor: Zomepirac sodium, a recently introduced non-steroidal anti-inflammatory drug, has been heavily promoted for use as an analgesic (1). I report a case of acute renal failure that was likely due to the use of zomepirac sodium.
A previously healthy 26-year-old male physician who was taking no prescribed or over-the-counter medications took one 50-mg tablet of zomepirac sodium for relief of a simple headache. He awoke the next morning (approximately 12 hours after ingestion) feeling nauseated and weak but went to work. During the day nausea persisted, diffuse abdominal and flank pains developed, and weakness progressed, forcing him
Learn more about subscription options.
Register Now for a free account.
RATNER SJ. Zomepirac and Renal Failure. Ann Intern Med. 1982;96:793. doi: 10.7326/0003-4819-96-6-793_1
Download citation file:
Published: Ann Intern Med. 1982;96(6_part_1):793.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only